Back to Search Start Over

Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome.

Authors :
Kidoguchi K
Kubota Y
Fujimoto S
Sakata Y
Kizuka-Sano H
Yamaguchi K
Ureshino H
Katsuya H
Ando T
Esaki M
Kimura S
Source :
Internal medicine (Tokyo, Japan) [Intern Med] 2021; Vol. 60 (10), pp. 1601-1605. Date of Electronic Publication: 2021 May 15.
Publication Year :
2021

Abstract

Cronkhite-Canada syndrome (CCS) is a rare polyposis disorder accompanied by alopecia and onychodystrophy. A 63-year-old man with a history of CCS and repeated embolism developed progressive thrombocytopenia and mild anemia. Laboratory testing, a bone marrow examination, and magnetic resonance imaging of the spine resulted in a diagnosis of concurrent aplastic anemia (AA). Paroxysmal nocturnal hemoglobinuria (PNH)-type cells were detected in a peripheral blood specimen. In addition, human leukocyte antigen (HLA) included DRB1*15:01 and DRB1*15:02. Mesalazine was discontinued in consideration of possible drug-induced pancytopenia. Immunosuppressive therapy ameliorated both the gastrointestinal symptoms of CCS and pancytopenia. A common autoimmune abnormality might underlie both CCS and AA.

Details

Language :
English
ISSN :
1349-7235
Volume :
60
Issue :
10
Database :
MEDLINE
Journal :
Internal medicine (Tokyo, Japan)
Publication Type :
Academic Journal
Accession number :
33994447
Full Text :
https://doi.org/10.2169/internalmedicine.6468-20